Similarly, in hepatocellular carcinoma, Listeria‐based vaccine promotes M0 and M2 differentiation in M1‐TAM, which increased tumor PD‐L1 and improved the anti‐PD‐1 therapy [38]. Here, PDCD1 is linked to hepatocellular carcinoma.